Understanding Fragile X Premutations and Their Effects
Fragile X Premutations, Mechanisms and Modifiers
This study is looking into how changes in a specific gene related to Fragile X can affect brain and reproductive health, with the goal of finding new ways to help people with these conditions feel better and have more treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10907680 on NIH RePORTER |
What this research studies
This research investigates the mechanisms and modifiers of Fragile X-associated disorders, which arise from changes in the FMR1 gene's CGG repeat. The study aims to explore the genetic factors and epigenetic changes that contribute to neurological and reproductive issues associated with these disorders. By examining the interactions between different conditions linked to Fragile X, the research seeks to identify potential therapeutic targets and develop effective treatments. Patients may benefit from a better understanding of their conditions and new treatment options that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with Fragile X syndrome, fragile X-associated tremor/ataxia syndrome, or fragile X-associated primary ovarian insufficiency.
Not a fit: Patients without any association to Fragile X disorders or those who do not carry the FMR1 gene mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for patients with Fragile X-associated disorders.
How similar studies have performed: Previous research has shown promise in understanding the mechanisms of repeat expansion disorders, but this approach aims to provide novel insights and potential breakthroughs.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Nelson, David Loren — Baylor College of Medicine
- Study coordinator: Nelson, David Loren
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.